Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M59.7Revenue (TTM) $M0.2Net Margin (%)-25,385.0Altman Z-Score-10.2
Enterprise Value $M18.5EPS (TTM) $-0.7Operating Margin %-26,128.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.4Pre-tax Margin (%)-25,385.0Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %-9.9Quick Ratio3.1Cash flow > EarningsY
Price/Sales2555-y EBITDA Growth Rate %-11.0Current Ratio3.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-77.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-171.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M117ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CYTR

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CYTR is held by these investors:



CYTR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Patterson Scott Bradford10% Owner 2013-12-03Buy284,979$2.44-72.13view
Patterson Scott Bradford10% Owner 2013-11-07Buy50,000$2.06-66.99view
Patterson Scott Bradford10% Owner 2013-04-01Buy4,083$2.7-74.81view
Patterson Scott Bradford10% Owner 2013-03-20Buy35,520$2.58-73.64view
Patterson Scott Bradford10% Owner 2013-03-20Buy3,980$2.61-73.95view
Patterson Scott Bradford10% Owner 2013-03-13Buy55,360$2.67-74.53view
Patterson Scott Bradford10% Owner 2012-10-22Buy180,000$2.51-72.91view
Patterson Scott Bradford10% Owner 2012-10-18Buy1,200,000$2.5-72.8view
Patterson Scott Bradford10% Owner 2012-06-28Buy44,824$5.14-86.77view
Patterson Scott Bradford10% Owner 2012-06-25Buy27,462$5-86.4view

Quarterly/Annual Reports about CYTR:

News about CYTR:

Articles On GuruFocus.com
CytRx Corporation Announces Proposed Public Offering of Common Stock Apr 27 2017 
CytRx to Present Aldoxorubicin Clinical Trial Data in Patients with Soft Tissue Sarcomas at the 2017 Apr 21 2017 
CytRx Announces FDA Agreement on Regulatory Pathway to Approval for Aldoxorubicin in Soft Tissue Sar Apr 19 2017 
Weekly CFO Buys Highlight: CYTR, API, CLGX, PLBC, ARTC Mar 05 2012 
Weekly CEO Buys Highlight: ULBI, BDE, ALNY, CTTR, GFN Feb 27 2012 
Weekly CFO Buys Highlight: CYTR, PZZI, AGYS, PLBC Feb 27 2012 
CytRx Corp. Reports Operating Results (10-K) Mar 11 2011 
CytRx Corp. Reports Operating Results (10-Q) Nov 08 2010 
CytRx Corp. Reports Operating Results (10-Q) Aug 09 2010 
CytRx Corp. Reports Operating Results (10-Q) May 06 2010 

More From Other Websites
CytRx Corporation Announces Proposed Public Offering of Common Stock Apr 27 2017
Penny Stocks to Watch for May 2017 Apr 27 2017
CytRx to Present Aldoxorubicin Clinical Trial Data in Patients with Soft Tissue Sarcomas at the 2017... Apr 21 2017
CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up Apr 20 2017
ETFs with exposure to CytRx Corp. : April 20, 2017 Apr 20 2017
Blog Coverage CytRx Announces FDA's Approval for New Drug Application Apr 20 2017
CytRx Announces FDA Agreement on Regulatory Pathway to Approval for Aldoxorubicin in Soft Tissue... Apr 19 2017
For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1 Apr 11 2017
CytRx Corp. :CYTR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Mar 21 2017
CytRx Reports 2016 Financial Results Mar 15 2017
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle Mar 08 2017
CytRx to Present at the 29th Annual ROTH Conference Mar 07 2017
CytRx to Present at the 19th Annual BIO CEO & Investor Conference Feb 06 2017
CytRx Granted Type B Pre-NDA Meeting with U.S. FDA for Registration Pathway with Aldoxorubicin as a... Jan 04 2017
Is the Options Market Predicting a Spike in CytRx Corp (CYTR) Stock? Dec 30 2016
CytRx Appoints Chief Medical Officer Dr. Daniel Levitt as Chief Operating Officer Dec 19 2016
How CytRx Corporation (CYTR) Stacks Up Against Its Peers Dec 14 2016
CytRx Corporation Announces $8.1 Million Registered Direct Offering of Common Stock Dec 13 2016
Leading Sarcoma Expert Dr. Earl W. Brien Joins CytRx Board of Directors Dec 02 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)